CREATINE KINASE-MB

被引:7
作者
APPLE, FS
机构
[1] Clinical Laboratories, Hennepin County Medical Center, Minneapolis, MN 55415
关键词
D O I
10.1093/labmed/23.5.298
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Creatine kinase (CK)-MB is the enzyme currently used as the definitive serum marker for the diagnosis or exclusion of acute myocardial infarction (AMI). This article reviews the characteristics of CK-MB, the methods and limitations of the new monoclonal anti-CK-MB antibody-based immunoassays, information on the diagnostic accuracy, clinical implications of serial and single enzyme levels, and recommendations for the optimal use of CK-MB. In addition, the role of serum CK-MB in monitoring reperfusion following thrombolytic therapy for patients with AMI is discussed.
引用
收藏
页码:298 / 302
页数:5
相关论文
empty
未找到相关数据